Efficacy of α-glucosidase inhibitors combined with dipeptidyl-peptidase-4 inhibitor (alogliptin) for glucose fluctuation in patients with type 2 diabetes mellitus by continuous glucose monitoring-Reference-Cited by-同舟云学术

Efficacy of α-glucosidase inhibitors combined with dipeptidyl-peptidase-4 inhibitor (alogliptin) for glucose fluctuation in patients with type 2 diabetes mellitus by continuous glucose monitoring

Published:2013-03-07 Issue:4 Volume:4 Page:393-398
ISSN:2040-1116
Container-title:Journal of Diabetes Investigation
language:en
Short-container-title:J Diabetes Invest

Author:

Kurozumi Akira¹,Okada Yosuke¹,Mori Hiroko¹,Arao Tadashi¹,Tanaka Yoshiya¹

Affiliation:

1. First Department of Internal Medicine; School of Medicine, University of Occupational and Environmental Health Japan; Kitakyushu Japan

Publisher

Wiley

Subject

General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jdi.12059/fullpdf

Reference22 articles.

1. The DECODE study group, European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis of Diagnostic criteria in Europe;Glucose tolerance mortality: comparison of WHO American Diabetes Association diagnostic criteria;Lancet,1999

2. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose, The Funagata Diabetes Study;Tominaga;Diabetes Care,1999

3. Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up;Hanefeld;Diabetologia,1996

4. Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods;Buse;Am J Cardiol,2007

5. Severe hypoglycemia and risks of vascular events and death;Zoungas;N Engl J Med,2010

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative effects of fixed‐dose mitiglinide/voglibose combination and glimepiride on vascular endothelial function and glycemic variability in patients with type 2 diabetes: A randomized controlled trial;Journal of Diabetes Investigation;2023-12-27

2. Effects of fixed-dose mitiglinide/voglibose combination on vascular endothelial function and glycemic variability in patients with type 2 diabetes: A randomized controlled trial;2023-08-28

3. Acarbose Add-on Therapy in Patients with Type 2 Diabetes Mellitus with Metformin and Sitagliptin Failure: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study;Diabetes & Metabolism Journal;2019

4. Glucose excursions and hypoglycemia in patients with type 2 diabetes treated with mitiglinide/voglibose versus glimepiride: A randomized cross-over trial;Journal of Diabetes;2018-04-11

5. An α-glucosidase inhibitor could reduce T-wave alternans in type 2 diabetes patients;Journal of Electrocardiology;2018-01